Murray Brunt
Impact in
-
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
- PARP inhibition in cancer therapy
- Cancer-related Molecular Pathways
-
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
Papers in
- Oncology 6
- Cancer Treatment and Pharmacology 4
- Cancer Diagnosis and Treatment 1
- Cancer-related Molecular Pathways 1
-
- Advanced Breast Cancer Therapies 5
- Prostate Cancer Treatment and Research 1
- Co-authors
- Robert C. Stein (2 shared papers)Peter Hall (1 shared paper)László Mangel (1 shared paper)Jacinta Abraham (1 shared paper)Nicholas C. Turner (1 shared paper)Gia Nemsadze (1 shared paper)Timothy Perren (1 shared paper)Stephen Chan (1 shared paper)
- Journals
- Cancer Research (3 papers)European Journal of Surgical Oncology (1 paper)Journal of Clinical Oncology (1 paper)Annals of Oncology (1 paper)Hematological Oncology (1 paper)
- Partner nations
- United KingdomCanadaFrance
In The Last Decade
Murray Brunt
8 papers receiving 66 citations
Peers
Comparison fields: 5 of 17
- Oncology 48
- Cancer Research 26
- Pulmonary and Respiratory Medicine 36
- Pathology and Forensic Medicine 12
- Genetics 5
Countries citing papers authored by Murray Brunt
This map shows the geographic impact of Murray Brunt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Murray Brunt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Murray Brunt more than expected).
Fields of papers citing papers by Murray Brunt
This network shows the impact of papers produced by Murray Brunt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Murray Brunt. The network helps show where Murray Brunt may publish in the future.
Co-authors
The 25 scholars most cited alongside Murray Brunt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 41 | |
| 2 | 2012 | 9 | |
| 3 | 2021 | 8 | |
| 4 | 2019 | 3 | |
| 5 | 2016 | 2 | |
| 6 | Quality of life (QOL) results of the UK TACT2 trial: more intensive chemotherapy for early breast cancer (EBC) has a measurable impact on patient-reported symptoms and functioning (CRUK/05/019) | 2015 | 2 |
| 7 | 2019 | 1 | |
| 8 | 2020 | 1 |
About Murray Brunt
Murray Brunt is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Molecular Biology and Pathology and Forensic Medicine, having authored 8 papers that have together received 67 indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (5 papers), Cancer Treatment and Pharmacology (4 papers), Breast Cancer Treatment Studies (3 papers), Lymphoma Diagnosis and Treatment (1 paper), Cancer Diagnosis and Treatment (1 paper), Prostate Cancer Treatment and Research (1 paper), Estrogen and related hormone effects (1 paper) and Cancer-related Molecular Pathways (1 paper). The work is most often cited by research in Oncology (48 citations), Cancer Research (26 citations), Pulmonary and Respiratory Medicine (36 citations), Pathology and Forensic Medicine (12 citations) and Genetics (5 citations). Murray Brunt has collaborated with scholars based in United Kingdom, Canada and France. Frequent co-authors include Robert C. Stein, Peter Hall, László Mangel, Jacinta Abraham, Nicholas C. Turner, Gia Nemsadze, Timothy Perren, Stephen Chan, Jean-Marc Ferrero and John Conibear. Their work appears in journals such as Cancer Research, European Journal of Surgical Oncology, Journal of Clinical Oncology, Annals of Oncology and Hematological Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.